Graincorp Reported FY17 EBITDA

Graincorp reported FY17 EBITDA  of $390m, up 53% on last year, but below market expectations. The market was looking for a stronger result given the largest east coast crop on record.

Storage & Logistics disappointed, as did the failed synergy targets from its’ Oils investment to date.

Looking out 12 months, we see FY18 earnings per share lower but the dividend remaining steady at $0.30 per share, placing the stock on a forward yield of 3.5%.

Our Algo Engine flagged a short signal under the lower high formation on the 9/11/2017, when GNC was trading at 8.76.

 

 

 

Sonic Healthcare – Valuation Review

We hold Sonic Healthcare in our ASX 50 model portfolio, following recent Algo Engine buy signal.

FY18 net profit is likely to be around $470m  on $5.5b in revenue, if we assume 5% EPS growth in FY19 and FY20 we get to a forecast net profit of $520m in FY20.

The above growth will see dividends expand from the current $0.77 per share, to $0.86 in 2020.

Like many top 50 companies, we see Sonic as a defensive contributor to portfolios but hardly at compelling value.  It’s only when adding a covered call option that the risk return scenario starts to add up.

We allow moderate capital growth and look to sell $22.50 calls on the other-side of the March dividend, helping us to drive 10 – 12% cash flow from SHL on an annualised basis.

 

 

 

 

 

Sydney Airports – Strong international traffic growth

SYD reported October 2017 traffic with total passenger growth of +3.8%. International growth was up +5.8%, while domestic growth was up 2.8%.

Strong international traffic growth should continue to underpin dividend per share growth of 2- 3%.

Sydney airport is trading near full value and investors should add a covered call option to enhance the yield.

We hold SYD in our ASX 50 model portfolio.

 

 

Is Retail Food Group In The Buy Zone ?

Shares of RFG have traded as high as $6.25 in January of this year. Since then the price has dropped over 30% to the current level of $4.40.

RFG is now priced at a trailing P/E of 12X , which is lower than the industry standard of 23X.

The stock is currently trading at -51% below its intrinsic level of $8.9. This mismatch indicates a potential opportunity to buy low as MD Andre Nell expects underlying net profits to rise about 6% in 2018.

Finally, its debt relative to equity is 54%, which has been diminishing over the past couple of years showing its capacity to pay down its debt.